Saturday, July 11, 2026

Drug profile · INN

trenonacog alfa

trenonacog alfa (IXINITY) is a coagulation factor ix exogenous protein.

EMA: application withdrawn Blood and blood forming organs (B02) B02BD12
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — trenonacog alfa
Class
Blood and blood forming organs (B02)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

trenonacog alfa (IXINITY) is a coagulation factor ix exogenous protein.

Key facts

INN trenonacog alfa
Brand IXINITY
Mechanism Coagulation factor IX exogenous protein
Target Coagulation factor IX
Therapeutic class Blood and blood forming organs (B02)
ATC code B02BD12

Mechanism of action

Coagulation factor IX exogenous protein

Primary target: Coagulation factor IX

Approval history

Authority Status Date
EMA application withdrawn

Related & competitor drugs

  1. apixaban Blood and blood forming organs (B01)
  2. berotralstat Blood and blood forming organs (B06)
  3. bivalirudin Blood and blood forming organs (B01)
  4. c1 inhibitor (human) Blood and blood forming organs (B06)
  5. clopidogrel Blood and blood forming organs (B01)
  6. dabigatran etexilate Blood and blood forming organs (B01)

Frequently asked questions

What is trenonacog alfa?

trenonacog alfa (IXINITY) is a coagulation factor ix exogenous protein.

What is the brand name for trenonacog alfa?

IXINITY is a marketed brand name for trenonacog alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.